|
Hopkins W E, Chen Z, Fukagawa N K. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease:enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion [J]. Circulation, 2004, (23):2872.
|
|
Burger M R, Burger A J. BNP in decompensated heart failure:diagnostic, prognostic and therapeutic potential [J]. Current Opinion in Investigational Drugs, 2007(7):929.
|
|
Hauptman P I, Sabbah H N. Reversal of ventricular remodeling important to establish and difficult to define [J]. European Journal of Heart Failure, 2007(4):325.
|
|
Akhtar N, Adil M M, Ahmed W. The role of leukocyte counts in patients with unstable angina pectoris or myocardial infarction;prognostic significance and correlation with plasma brain natriuretic peptide (BNP) levels [J]. Journal of the Pakistan Medical Association, 2011(1):51.
|
|
Giallauria F, Cirillo P, Lucci R. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction:favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide [J]. European Journal of Cardiovascular Prevention and Rehabilitation, 2008(1):113.
|
|
Miller W L, Hartman K A, Hodge D O. Response of novel biomarkers to BNP infusion in patients with decompensated heart failure:a multimarker paradigm [J]. J Cardiovasc Transl Res, 2009(4):526.
|
|
Kim S A, Rhee S J, Shim C Y. Prognostic value of N-terminal probrain natriuretic peptide level on admission in patients with acute myocardial infarction and preserved left ventricular ejection fraction [J]. Coronary Artery Disease, 2011(3):153.
|
|
Ezekowitz J A, Théroux P, Chang W. N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction [J]. Canadian Journal of Cardiology, 2006(5):393.
|
|
Buchner S, Debl K, Barlage S. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention:a marker of ischemic burden, reperfusion and outcome [J]. Clinical Chemistry and Laboratory Medicine, 2010(6):875.
|
|
Jernberg T, James S, Lindahl B. NT-ProBNP in nonST-elevation acute coronary syndrome [J]. Journal of Cardiac Failure, 2005, (5 Suppl):S54.
|
|
Machado M, Falco L M, Ravara L. The clinical role of natriuretic peptides-importance of BNP and NT-proBNP.Implications in heart failure and acute coronary syndrome [J]. Revista Portuguesa De Cardiologia, 2004, (7/8):1005.
|
|
Ezekowitz J A, Théroux P, Welsh R. Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI):why should it be better than baseline [J]. Canadian Journal of Physiology and Pharmacology, 2007(1):173.
|
|
Kwon T G, Bae J H, Jeong M H. N-terminalpro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention [J]. International Journal of Cardiology, 2009(2):173.
|
百度学术
下载:
苏公网安备 32100302010246号
